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ABSTRACT 
 
 
 
 Stem cell research is one of the most promising medical technologies in today’s world; 
doctors and scientists potentially have the ability to prolong and save millions of lives.  
However, ethical and legal issues arise when working with one key type of stem cell, embryonic 
stem (ES) cells, prohibiting federal funding to derive new ES cell lines.  In this IQP, we 
investigated the various types of stem cells, their applications, and their ethics and legalities.  
Based on this information, the IQP authors made recommendations and conclusions.   
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PROJECT OBJECTIVES 
 
 
The objective of this IQP was to research and discuss the technological, scientific, social, 
and political effects of stem cells on society. The purpose of chapter 1 was to identify the various 
types of stem cells and their potencies. The purpose of chapter 2 was to explain different ways 
stem cell research can be applied in scientific and medical studies, showing both successful and 
future experiments. The purpose of chapter 3 was to show the ethical views of the five major 
world religions on stem cell research, including adult stem cells versus embryonic stem cells.  
Finally the purpose of chapter 4 was to examine the political effects of stem cell research around 
the world by examining laws that govern this controversial technology.  
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Chapter-1:  Stem Cell Types and Sources 
 
Advances in stem cell research have greatly evolved over the past twenty years, bringing 
with them questions concerning the usefulness and necessity of these studies, as well as 
questions pertaining to legalities and ethics concerning this field of science. The great debate 
stirred by stem cells has both political and social effects which often times overshadow the 
scientific progress that has been made. Stem cells have been found to possess nearly endless 
biological and therapeutic uses, and they have the potential to make profound changes on both 
medical and scientific fronts. Many people, from scientists to those merely interested in these 
newly developed studies, have become more concerned with the advances in this field and are 
looking for answers surrounding the history, politics and ethics of stem cell research.  The 
purpose of this first chapter is to introduce you to the topic of stem cells, paying special attention 
to describing what they are, their various types, and where we isolate them from. 
 
Stem Cell Introduction 
 A stem cell is just another type of cell in the body so all the hype concerning them brings 
up questions as to why they are so special. Stem cells are found in a variety of places in the body 
and have three general qualities. These cells are unspecialized, are able to divide with no limit, 
and they have the capability of becoming more specialized cells in the body.  For example, stem 
cells in the brain help produce different cells in the nervous system; while hematopoietic stem 
cells in bone marrow produce all the various types of blood cells. Stem cells are also used as a 
sort of repair system, continually replenishing cells needed throughout the body. In the future 
stem cells may lead the way for treating diseases like Parkinson’s, diabetes, and heart disease. 
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Based on these fundamental properties of stem cells, many questions have arisen centering on 
why they remain unspecialized, how do they continue to duplicate, and exactly which signals 
trigger them to become a certain specialized cell. No other type of cell in the body comes close 
to having such unique characteristics and far reaching effects on biology or society, which 
explains the mass interest in stem cells. 
 
Stem Cell Categories 
Stem cells have been researched since the mid 1800’s with the discovery of plant stem 
cells, and the 1960’s with the discovery of mouse hematopoietic stem cells.  But widespread 
interest has boomed during the past few years with the discovery of human embryonic stem cells 
that have great medical potential. Stem cells are divided into two distinct groups, embryonic 
stem (ES) cells and adult stem cells (ASCs). These groups each have diverse purposes and 
qualities, and each kind is being intensely studied to uncover their true potential.  
Early research on stem cells dates back to 1886, when the term was coined by William 
Sedgwick to describe the regenerative parts of plants. By now the term has come to have a much 
greater meaning.  In the 1960s, along with the advancement of in vitro fertilization (IVF) in 
animals and humans, animal ES stem cells began to be studied in depth, and these studies 
brought a much deeper understanding in this topic.  The stem cell topic blew wide open in 1998 
with the discovery of methods for isolating and culturing human ES cells, which paved the way 
for potential human ES therapies (Figure-1).  In order to fully grasp more recent experiments and 
the effects they have had on science it is important to know the various types of stem cells and 
the questions that surround them. 
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ES Cells 
ES cells are obtained from blastocysts, that are simply embryos that haven’t yet 
implanted in the uterus,  Embryos are created by IVF (Figure-1, upper left), and grown in vitro  
for 5-6 days until they form a hollow ball of cells (diagram center).  The outer layer is termed the 
trophoblast which forms the placenta.  The inner cell mass (blue in the diagram), constitutes ES 
cells which normally form the embryo. Normally these embryos are created in IVF clinics by 
couples for reproductive purposes, however once the couple is done having children, and with 
their consent, the excess IVF embryos are sometimes used for biological research. 
 
 
 
 
 
 
Figure-1:  Diagram of the Isolation of ES cells 
from IVF Embryos.  (Yu, 2006) 
 
 
 
 
 
 
 In the few days after fertilization occurs, all the cells in the embryo are unspecialized. 
These cells are referred to as totipotent or omnipotent; simply meaning they have the potential to 
become any cell in the body, but the specific cell type is not determined yet.  After five days, the 
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outer cells in the embryo specialize to become the trophoblast which eventually forms the 
placenta.  The ES cells reside in the inner cell mass (ICM). If the blastocyst implants in the 
uterine wall, the ES cells quickly start to differentiate severely limiting their therapeutic use, but 
if removed before implantation (or simply grown in vitro) and kept under proper conditions they 
are able to remain unspecialized with the possibility of becoming almost any type of cell in the 
body from the primary germ layers (except the placenta).  For this reason, ES cells are 
considered pluripotent, not totipotent.  The three layers formed by ES cells are ectoderm, 
mesoderm, and endoderm (Figure-2).  However, and most importantly, ES cells can develop into 
germ or reproductive cells. These cells are seen as invaluable due to the fact that they are able to 
produce endlessly. This simply means ES cells (or cell lines derived from them) have the 
capability to offer a continuous supply of oocytes without any further female volunteers than was 
required to obtain the initial embryo. 
 
 
 
 
Figure-2:  Formation of Three Primary Cell Layers by ES 
Cells.  (Yu, 2006) 
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Adult Stem Cells 
 
The second common grouping of stem cells are adult stem cells (ASCs). These cells are 
found throughout the body, and primarily serve the body by regenerating damaged tissues by 
dividing and aiding areas where cells are lacking. Unlike embryonic stem cells, there isn’t much 
controversy surrounding the use of adult stem cells since they do not involve the destruction of 
an embryo. Adult stem cells are responsible for generating all the cells that come from the organ 
they originate from. Although there are many different types of tissues that contain adult stem 
cells (for example brain, liver, bone marrow, blood, muscles, and skin) they are not very 
abundant in adult tissues.  Though there are many known sources for adult stem cells, each type 
has a limited differentiation potential, and they are harder to grow than ES cells.  Some adult 
stem cells have been shown to transdifferentiate, which is the ability for these cells to generate 
cell types of another kind of tissue.  
Adult animal stem cells were first identified in the 1960’s with the discovery of mouse 
hematopoietic stem cells.  Adult stem cells in bone marrow include hematopoietic stem cells 
(HSCs) and bone marrow stromal cells.  These cells were found to generate all sorts of tissues 
within the body.  
 
Hematopoietic Stem Cells 
The first discovered, and most recognizable of all the types of adult stem cells are the 
hematopoietic stem cells. These stem cells are one of the two known types of stem cells found in 
bone marrow, and have been used for over 40 years to treat patients with certain illnesses 
 10
including blood disorders and some cancers, especially leukemia. Another good source of HSCs 
is umbilical cord blood and the placenta. This type of stem cells are known to produce red blood 
cells, platelets, neutrophils, basophils eosinophils, monocytes, B lymphocytes, T lymphocytes, 
killer cells, and macrophages (Figure-3). Also HSCs have the plasticity to turn into skeletal and 
cardiac muscle cells, liver cells, and some brain cells. These cells are very similar to white blood 
cells in shape and size which makes identifying them difficult. One of the few ways to tell the 
difference between hematopoietic stem cells and white blood cells is by surface proteins markers 
on each type of cell that can be used in fluorescence activated cell sorting (FACS) to purify each 
type. 
 
Figure-3:  Diagram of Hematopoiesis.  Shown are the isolation of hematopoietic stem 
cells from bone marrow (left), and their ability to form all the cellular components of 
blood (right) including myeloid and lymphoid lineages.  (Domen, 2006) 
 
 
 11
One reason why HSCs are so well known is their enormous success in bone marrow 
transplants.  These stem cells have either been taken out of an individual and then replaced 
within their own body (autologous transplant), or transplanted from another source (heterologous 
transplant).  And due to the prevalence of HSCs in cord blood, it has become much more 
common for parents to save the umbilical cords of their children in case the need for these later 
in life. By using any of these techniques, HSCs are miraculously able to treat diseases such as 
multiple sclerosis, scleroderma, lupus, and leukemia.  
 
Mesenchymal Stem Cells 
The second type of stem cell found within the bone marrow are stromal or mesenchymal 
stem cells (MSCs). The term stromal refers to the cells’ ability to act as connective tissues and 
the term mesenchymal refers to the fact that this connective tissue comes from the mesoderm. 
These adult stem cells can produce bone cells, cartilage cells, fat cells, and connective tissues 
such as tendons. They can also differentiate into cardiac and skeletal muscle cells.  Due to this 
amazing plasticity, more research on these cells is underway. Right now this process is very slow 
but with the aid of mesenchymal cells wounds could heal at a much faster rate. 
 
Neural Stem Cells 
Adult stem cells are also responsible for producing the cells that make up the nervous 
system in the body, which includes the brain and spinal cord. The first place these cells are found 
is the brain and here neural stem cells (NSCs) can produce non-neuronal cells (astrocytes and 
oligodendrocytes), as well as neurons. Neurons are mainly responsible for transporting messages 
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through the nervous system. Glia are supporting cells. NSCs also have the plasticity to turn into 
blood cells and skeletal muscle cells.  
Originally it was believed that cells of the brain were unable to renew themselves. But 
research has uncovered the fact that in some areas of the brain neurons are able to replicate. The 
first of two areas in the brain where neurons are able to develop is the subventricular zone of the 
lateral ventricle where neurons aiding in the sense of smell are generated. The second area is the 
subgranular zone of the dendrite gyrus where granules (very small cells) are formed. The brain 
still does not have the high regenerative capacity of other tissues like blood, so it is still 
susceptible to injury and illness. But the discovery of NSCs offers hope for the eventual 
treatment of neurodegenerative diseases that were once thought to have no cure.  
The first step in treatments is the isolation of neurons but this procedure is very difficult 
because only 1 in 300 cells is a neural stem cell. The next step to treatment involves purification 
of the NSCs, which is a highly difficult process which is being intensely studied. 
 
Cardiac Stem Cells 
Another vital area in the body that contains stem cells is the heart. Heart disease is a 
common medical problem that may be positively affected by stem cell research. Cardiomyocytes 
are heart muscle cells responsible for contracting and expelling blood from the ventricles. Heart 
disease causes these cells to be destroyed; however cardiac stem cells can actually specialize and 
form these heart cells. Cardiac stem cells can also form the inner lining and walls of blood 
vessels. Many studies with mice have been crucial in proving that cardiac tissue can be 
regenerated.  Many questions still remain about the exact potential of cardiac stem cells, but with 
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more research they could potentially lead to large advancements in the treatment of these 
problems in humans. 
 
Stem Cell Sources 
Various sources for stem cells are available throughout the body, and more sources are 
being revealed with growing research. At this time there are at least seven sources for stem cells 
including:  existing ES  lines, fetal tissue, umbilical cord blood, various adult tissues, extra 
embryos generated for reproduction through in vitro fertilization, embryos specifically developed 
for research through in vitro fertilization, embryos generated through somatic cell nuclear 
transfer, and embryos created through artificial parthenogenesis. Each of these sources is able to 
give a different type of cell which is why research is done in all these areas. 
 
Cell Lines 
Stem cell lines are a major source of stem cells, and simply put are a collection of cells 
that have all originated from one initial cell. Stem cell lines can either be embryonic or adult 
however the adult stem cell lines are much more limited than embryonic stem cell lines, and can 
divide fewer times. Right now laws surrounding the production of stem cells lines vary greatly 
from country to country, but stem cell registries keep track of the stem cell lines in each country.  
 
Fetal Tissue 
The next source of stem cells is fetal tissue, however all the cells gained from fetuses are 
adult stem cells. Cells from fetal tissue include hematopoietic blood cells, primordial germ cells, 
and neural stem cells for treating Parkinson’s. Embryonic germ cells (EGCs) are interesting 
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because if they are obtained from an aborted or undeveloped fetus they have properties of both 
embryonic and adult stem cells. They are similar to embryonic cells because they can become 
any cell excluding the placental cells, but like adult cells are unable to regenerate indefinitely. 
These cells are highly debated due to ethics surrounding them and there uses as they are usually 
obtained from aborted fetuses that are far older than 5 day old IVF embryos used to obtain ES 
cells.  
 
IVF Embryos 
Another source of stem cells are artificially produced embryos. Often when a couple 
decides to use in vitro fertilization, extra embryos are produced and these are frozen for future 
use, but once the couple has finished having children, the excess embryos are either destroyed or 
are donated for research.  In 2002, nearly 400,000 embryos were frozen, and nearly 3% were 
donated to science. This seems like a large number to be used for research, however due to 
problems with preserving embryos, the number of viable embryos gets knocked down to 275.  In 
the case of embryos specifically created for research, the same types of cells would be 
developed, but this process creates controversy with some people if the embryos were not 
created for reproductive purposes. The cells gained through this process carry a greater ethical 
weight due to the fact that some people believe this exploits both women and the embryos that 
are created. The benefits of this process may eventually outweigh the risks, but at the moment 
the fact that IVF reproductive embryos are easier to obtain makes them far more usable. 
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SCNT 
Somatic cell nuclear transfer or SCNT is another method for obtaining ES cells. SCNT is 
sometimes referred to as “therapeutic cloning” and is used in animal stem cell research and in 
regenerative medicine. SCNT has not yet been achieved in humans.  A somatic cell is any cell in 
the body excluding sperm and egg cells. During SCNT, the nucleus of a somatic cell (usually a 
skin fibroblast cell) is removed and replaces the nucleus of an egg cell that has already had its 
nucleus removed. After this process occurs, the egg containing the nucleus of a body cell begins 
to divide and after many divisions will form a blastocyst from which ES cells can be isolated that 
are genetically identical to the donor of the skin cell nucleus. The key to this procedure is that the 
blastocysts will contain genetic material that is almost identical to the original cell it came from. 
This technique has been used to create clones of sheep, goats, dogs and a handful of other 
mammals, and has been used to create mice and primate ES cell lines (but not human).   
SCNT seems to have the vast potential to cure or aid in the treatment of many diseases, 
since ES cells could be obtained that would not be immunorejected by a patient.  But 
nevertheless there are still severe limitations on this method. There is no way to guarantee this 
method will work and often there are many more lost clones than successful clones. Also this 
process has to be done by hand and is very exhausting in terms of resources used.  Most 
importantly, is the fact that this technique has not been able to create ES cell lines from human 
cells.  There have been claims of human cell lines derived via SCNT in South Korea, but these 
claims were since withdrawn due to data fabrication. Controversy surrounds this procedure and 
with future progressions it seems the ethical and moral questions will only grow. 
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Parthenogenesis 
Another procedure discussed in this chapter for obtaining human stem cells is the method 
of creating embryos through artificial parthenogenesis. In nature, parthenogenesis is an asexual 
reproductive process for producing worker ants and worker bees in insects.  This process does 
not naturally occur in primates or humans, but artificial parthenogenesis occurs when an egg is 
stimulated by chemical or physical influences in the absence of sperm. These stimulations mimic 
those of a sperm cell when it is fertilizing an egg therefore this action causes the egg to duplicate 
and eventually form an embryo. This technique has successfully created parthenote ES cell lines 
from primates (Cibelli et al., 2002), but human embryos only containing six cells which is not 
old enough to obtain ES cells. The blastocyst that is formed by this method however only 
contains genetic information from the egg making matchups between donors and recipients 
easier if this process is ever used in disease treatment. The embryos created during this process 
don’t have the capability to develop to full term, which may alleviate some ethical issues; since 
there is no chance of the embryo developing, no prospective life is lost. 
 
ANT 
One more much recent form of obtaining stem cells still being developed is known as 
Altered Nuclear Transfer (ANT).  ANT claims to be a technological approach to obtain human 
pluripotent cells, which function the same as ES cells, without creating or destroying human 
embryos. This method is similar to SCNT however the cells and nuclei used are altered prior to 
the transfer. Due to these genetic alterations, no embryo forms, but pluripotent cells are able to 
be produced.  For some people this technique is the perfect way to alleviate the moral dilemmas 
surrounding the destruction of viable embryos, however some feel it is just as immoral to create 
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a ball of mutant cells. This technique is still very much in the beginning stages but at the moment 
the idea of this process is very promising.  
 
Chapter-1 Conclusion 
The research performed to date on stem cells has paved the way for developing many 
new treatments for a variety of diseases. This chapter showed that stem cells are not all alike, so 
great care should be paid by laypersons claiming they are for or against stem cells since ethical 
concerns vary greatly depending on the type of stem cell being discussed.  The potential this 
research has showed is immeasurable, and new progress occurs almost everyday. With this 
progress many questions arise both politically and ethically, and the future of stem cell research 
is still very uncertain. Nevertheless, many uses of stem cells have been discovered and everyday 
they are studied, more knowledge comes to scientists. 
  
Chapter-1 Bibliography 
 
 
Bjorklund A, Lindvall O (2000) Self Repair in the Brain.  Nature 405:  892-895. 
 
Cassidy R, Frisen J (2001) Stem Cells on the Brain.  Nature  412: 690-691. 
Chamany K (2004) Stem Cell Primer. 
http://www.garlandscience.com/textbooks/cbl/pdflibrary/stemcells_primer.pdf 
Earll, CG (2005) “Adult Stem Cells: It's Not Pie-in-the-Sky”. Focus on the Family. 
http://www.family.org/cforum/fosi/bioethics/facts/a0035420.cfm 
 
Frequently Asked Questions on Stem Cell Research (2006) International Society for Stem Cell 
Research. http://www.isscr.org/public/faq.htm 
 
Hematopoietic Stem Cells (2005) NIH, Stem Cells, Chapter-5. 
http://stemcells.nih.gov/info/scireport/PDFs/chapter5.pdf 
 
 18
Huettner, Jim (2006) Neurons From Stem Cells.  Washington University St. Louis. 
http://www.cellbio.wustl.edu/faculty/huettner/nfsc1.htm 
 
Kirschstein R and Skirboll LR (2001)  “Stem Cells: Scientific Progress and Future Research 
Directions”. National Institutes of Health, Department of Health and Human Services.  
http://stemcells.nih.gov/info/basics/ 
 
Klimanskayza I, Chung Y, Becker S, Lu S, Lanza R (2006) Human Embryonic Stem Cell Lines 
Derived from Single Blastomeres.  Nature 444: 481-485. 
 
Lee BC, Kim MK, Jang G, Oh HJ, Yuda F, Kim HJ, Shamim MH, Kim JJ, Kang SK, Schatten 
G, Hwang WS  (2005) Dogs cloned from adult somatic cells.  Nature,  Aug 4, 436(7051): 641.  
Snuppy, the world’s first cloned dog. 
 
McKay, Ron (2000) Stem Cells:  Hype and Hope.  Nature, 406: 361-364. 
 
MedIndia.com (2006)  Stem Cells-Fundamentals.  Medindia Health Network Pvt. Ltd.  
http://www.medindia.net/patients/patientinfo/stemcells.htm 
 
National Institute of Health (2005) “Stem Cell Basics.” Stem Cell Information.    
http://stemcells.nih.gov/info/basics/basics2.asp 
 
Philipkoski, Kristen (2003) Stem Cells Heal a Broken Heart. 
http://www.wired.com/news/medtech/0,1286,57944,00.html 
 
Rebuilding the Nervous System with Stem Cells (2005) NIH, Stem Cells, Chapter-8.  
http://stemcells.nih.gov/info/scireport/chapter8.asp 
 
Stem Cell Basics (2005) National Institutes of Health, Department of Health and Human 
Services.   http://stemcells.nih.gov/info/basics/ 
Stem Cell Laws (2005)  http://library.thinkquest.org/04oct/00053/ab_laws.html 
 
Temple S (2001) The Development of Neural Stem Cells.  Nature  414: 112-117. Review.  
 
Touchette N (2004) Stem Cells Found in the Heart. 
http://www.genomenewsnetwork.org/articles/10_03/cardiac.shtml 
 
What Are Stem Cells? (2003)  American Federation for Aging Research.  
http://www.infoaging.org/toti 
 
Wikipedia, The Free Encyclopedia.  Wikipedia Foundation, Inc. 
http://en.wikipedia.org/wiki/ 
 
Yu J, Thomson JA (2006) Embryonic Stem Cells.  NIH Publication. Bethesda, MD: 
Regenerative Medicine. Retrieved Feb 13, 2008 from 
http://stemcells.nih.gov/staticresources/info/scireport/PDFs/Regenerative_Medicine_20 
6.pdf 
 19
Chapter-2:  Stem Cell Applications 
 
Stem cells have the unique ability to form into millions of dissimilar cells, ranging from 
blood to muscle to nerve cells. In doing this, they can be used to heal many diverse areas of the 
body when damaged, thus stem cells are strongly being explored for various medical issues, 
including autoimmune disorders, genetic diseases, Parkinson’s, Alzheimer’s, cancer, and stroke. 
The continued research and development of stem cells and their treatments offer hope to a 
healthier future for millions of people throughout the world.  The purpose of this chapter is to 
help document successful therapies currently being used in both animals and humans, paying 
special attention to distinguish between embryonic stem (ES) cell therapies versus therapies 
using adult stem cells (ASCs), since different ethical and legal issues pertain to each type.  
 
Cancer Treatment Using Stem Cells 
One of the most used treatments of stem cells today is that for various cancers. To date, 
hematopoietic stem cells (HSCs) from bone marrow are being used to salvage patients immune 
systems after high doses of chemotherapy. The use of bone marrow transplants, containing 
HSCs, has been in practice for about 40 years now, and has already saved thousands of lives 
(Emedicine).  Hematopoietic stem cells are found within blood, bone marrow, or umbilical cord 
blood, but they are traditionally isolated from bone marrow.  These cells have the ability to 
renew themselves, or to differentiate to a variety of specialized blood cells, thus they can form 
immune system cells.   
Acquiring HSCs from a donor’s bone marrow requires a local anesthetic, and insertion of 
a needle into the hipbone (Figure-1).  The deep red bone marrow is drawn out, sometimes grown 
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in vitro, then transferred to the receiving patient.  If a donor has been treated with hormones to 
stimulate the release of HSCs into the peripheral blood, the HSCs can be isolated by aphaeresis. 
Aspheresis is the process in which a donor’s blood is withdrawn from the body, sent through a 
machine that filters out the white blood cells, and then the red blood cells are returned to the 
body.  For this particular type of procedure, patients are injected with cytokine, a granulocyte 
colony stimulating factor that coaxes the HSCs into migrating from the bone marrow to the 
blood in greater numbers. Recent research has shown that peripheral blood harvesting yields 
better cells for transplants and is medically speaking easier on donors (Surgery Encyclopedia).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure-1:  Diagram of a Bone Marrow Transplant.  The upper left diagram denotes the 
formation of a variety of blood cell types from HSCS present in bone marrow.  The upper 
right diagram shows the extraction of bone marrow using a syringe.  The lower left 
diagram shows the processing of bone marrow to enrich HSCs, and the lower right shows 
a patient receiving an infusion of processed bone marrow. (Surgery Encyclopedia) 
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Hematopoietic stem cells in umbilical cord blood are extremely high in numbers. The 
umbilical cord and placenta are easily accessible, because they are delivered with the baby and 
most often discarded.  The umbilical cord blood cells can be saved for research purposes, being 
collected and frozen with liquid nitrogen at the cord blood bank until they are needed for 
donation.  Research has shown that this source of HSCs can prolong a child’s life for up to eight 
years.  HSCs isolated from cord blood have also been shown to produce less graft-versus-host 
disease, that sometimes occurs during stem cell transplants (Viacord, 2007).  
Although the use of HSCs to treat cancer patients is well established, the use of 
embryonic stem cells to treat cancer is still under development.  Researchers at the University of 
Wisconsin-Madison are working to identify a set of molecular markers that distinguish normal 
ES cells from cancer-type ES cells (Wikipedia).  Some cancers are currently thought to arise 
from embryonic stem cells that have become mutated to cause tumors.  Scientists are hoping to 
learn why the cancer caausing stem cells are behaving this way, and how the defects arise. Stem 
cells are virtually immortal, but when scientists separated tumor cells to allow them to grow in 
culture, few were able to revamp the tumor, indicating another type of cell (a cancer stem cell) 
was causing the tumors. These cancer stem cells are also believed to be responsible for the 
resistance to drugs and treatments for cancers. If scientists are able to gain a greater knowledge 
of these cancer stem cells, they could potentially develop a new, effective ways to treat patients 
suffering from cancer.  
 
Treatment of Diabetes Using Stem Cells 
Researchers have also found promising information leading to the treatment of diabetes.  
In type I diabetes, an autoimmune response destroys pancreatic β-cells, eliminating or 
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diminishing their ability to produce insulin.  Putative stem cells found within the liver, central 
nervous system, spleen and bone marrow are able to differentiate into insulin producing cells 
(abcnews). The stem cells could work to offer treatment for Type I diabetes because the damage 
in this type is localized to one particular cell type that should be relatively easy to produce.  One 
of the most important aspects in using adult stem cells for the treatment of diabetes is to 
recognize the pancreatic precursor cell that generates the β-cell.  Stem cells would need to be 
able to differentiate into β-cells that produce insulin, migrate to the damaged tissue, and further 
differentiate to maintain β-cell mass. However, with this process, it would be necessary to first 
diminish the autoimmune destruction of beta cells, otherwise the transplanted stem cells will also 
be destroyed.   
 Another possible treatment for diabetes being researched is the use of a patient’s own 
hematopoietic stem cells.  The stem cells are harvested from a person’s own blood, engineered to 
be immune to attack by the immune system, then after the patient’s immune cells are destroyed 
through a chemical process the patient’s harvested stem cells are injected back into the body 
where they are expected to rebuild the immune system. The hope in this procedure is that the 
new immune cells will not attack the beta cells within the pancreas. If stem cells were to offer 
treatment among diabetics, it would make millions of people’s lives simpler.  
 
Treatment of Heart Attacks Using Stem Cells 
Stem cells are also being researched as a possible treatment for damaged heart muscles 
following heart attacks. Studies have shown that mouse and human HSCs cells can potentially 
help in regenerating damaged myocardium in animal models and in humans (National Insitutes 
of Health).  Research has shown mouse and human HSCs being able to differentiate 
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spontaneously to form endothelial and smooth muscles.  Here a catheter is inserted into a blood 
vessel, and then an inflated device is used to widen the blocked coronary artery (Figure-2). A 
sample of bone marrow is taken and from this the HSCs are isolated.  Later, these stem cells are 
injected into the heart through the catheter where they develop into new heart muscle cells.   
Bone marrow derived endothelial progenitor cells are a type of cell the body transports 
into the peripheral blood to respond to ischemia. Endothelial progenitor cells are able to target 
ischemic areas and become new heart muscle.  If injected intravenously after a heart attack, these 
cells can target the damaged area within two days, in effect preventing left ventricular 
remodeling and cardiomyocyte apoptosis (Seattle Times). 
 
 
 
Figure-2:  Diagram of the Insertion of 
a Catheter into a Blood Vessel.  
Catherization has been used to insert 
stem cells into a heart by allowing them 
to be delivered immediately upstream 
into a cardiac vein (number-4 in the 
diagram) (National Institutes of Health).   
 
 
 
 
Human embryonic stem cells have also been revealed to differentiate into myocytes with 
structural and functional characteristics of cardiomyocytes (National Institutes of Health). ES 
cells transplanted into ischemically-injured myocardium in rats were able to differentiate into 
normal myocardial cells that were viable for up to four months (National Institutes of Health).  
Skeletal myoblasts were found to repopulate in the scar tissue of the rat’s damaged heart causing 
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significant improvement in ventricular function.   In one ES experiment done on mice, ES cells 
were used to replace damaged heart muscle.  The stem cells were chemically treated, and heat 
was applied allowing them to differentiate into heart muscle cells that are able to survive and 
grow in nearly one hundred percent of the animals tested.  Although only ten percent of the heart 
damage was restored, that was sufficient to prevent further heart failure (Seattle Times).   
Researchers have also succeeded in producing large quantities of cardiac stem cells 
isolated from human hearts taken from residual material from open heart surgeries. Researchers 
isolated the cardiac stem cells and grew them in a laboratory. The stem cells then matured into 
fully developed heart muscle cells that could function normally. The advantage to this cardiac 
stem cell method is that scientists are able to fully control this process and produce an unlimited 
amount of heart muscle cells.  Inclusing their applications for heart attacks, these newly 
developed cardiac stem cells will be used in research to find a cure for many different genetic 
diseases if they can be engineered to express key therapeutic genes. 
 
Treatment of Parkinson’s Disease Using Stem Cells 
Stem cells are also being researched as a potential therapy for Parkinson’s disease. 
Roughly 1.5 million people in the United States suffer from this neurodegenerative disease. 
Parkinson’s disease is caused by a loss of nerve cells within the substantia nigra of the brain, 
which produces the neurotransmitter dopamine. Although patients have been treated with the 
drug L-dopa, its success is temporary, and as symptoms worsen over time the effects of the drug 
diminish.  Scientists are working towards cultivating three types of stem cells: ES cells, HSCs, 
and adult neural stem cells (NSCs), to transform into dopamine producing nerve cells to reverse 
 Parkinson’s disease. If stem cells are able to perform this act they could conceivably replace the 
lost nerve cells (Figure-3).  
As one example, scientists cultivated HSCs from bone marrow and differentiatied them 
into functioning dopamine producing nerve cells in mice (DzFacts). These new nerve cells 
generated dopamine and were able to transmit nerve s
symptoms, and the success with animal models, Parkinson’s disease is said to be one of the most 
anticipated applications for stem cells and regenerative medicine. 
 
 
 
 
 
 
 
 
Figure-3:  Use of Transplanted Stem Cells to 
caused by the death of cells in the substantia nigra that produce dopamine (panel
transplanted to this area (panel-2) differentiate into dopamine producing cells (panel
allowing the dopamine to functio
 
 
Treatment of Spinal Cord Injuries Using Stem Cells
One very exciting application for stem cells is in treating spinal cord injuries. “Spinal 
cord injuries leave approximately 250,000 Americans paralyzed
occur when nerve axons are severed and scar tissue accumulates at the wound site.  This 
accumulation of scar tissue hinders nerve fiber regeneration which leads to paralysis. Adult 
25
ignals.  Due to the severity of the 
 
Produce Dopamine.  Parkinson’s disease is 
-1).  HSCs 
-3) 
n normally as a neurotransmitter (panel-4).  (CSA)  
 
” (WebMD). Spinal cord injuries 
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NSCs found in the spinal cord propagate gradually or infrequently, and for most injuries are 
unable to regenerate the cord on their own.  In animal models, it was recently demonstrated that 
implanting NSCs at the injury site can restore some degree of function to paralyzed primates and 
rodents, especially when the stem cells are delivered soon after the cord injury prior to scar tissue 
formation.  Scientists have even developed methods for marking the stem cell population to map 
their behavior, thus increasing their ability to definse which conditions increase their survival at 
the wound. The mapping procedure shows that the injected stem cells are proliferating and 
relocating to the injury site, and differentiating.  
Another method scientists are working towards for treating spinal cord injuries involves 
genetically modifying the stem cells to allow them to help prevent the formation of scar tissue. 
Scarring prevents stem cell transplantation from sparking nerve growth, so researchers are 
working towards developing a specialized astrocyte, or support cell, to aid the process.  In a rat 
experiment, the rats were found with less scar tissue and less nerve damage, and were able to 
walk normally within two weeks of the treatment.  The ability of stem cells to become various 
cell types makes researchers believe that the regulation of their differentiation into both neurons 
and astrocytes could help repair damaged nerve cells.  
 
Chapter-2 Conclusions 
Human clinical applications of stem cells are apparent in some areas of medicine, 
although there is an immense need to expand human trials. Human applications of stem cells are 
mostly limited to the use of HSCs to treat blood disorders and specific cancers, although some 
individual experiments have been done with other types of stem cells.  With further exploration, 
stem cells possibly will offer cures for a much broader area of medicine.  Over the years, 
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scientists have continued to learn more about stem cells and their applications in various medical 
areas. Important findings have occurred since the 1960’s, when scientists first discovered self-
renewing cells in the bone marrow of mice.  ES cells have been used in a variety of animal 
models for disease. And ASCs have been discovered in at least 10 different types of tissues.  As 
we will see in subsequent chapters, the ASCs have fewer ethical concerns than ES cells, but they 
are much harder to identify and grow.  The development of knowledge through scientific and 
medical research offers rewards for millions suffering from various diseases.  Stem cell research 
has the promise of offering stunning results in medicine.  
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Chapter-3:  Stem Cell Ethics 
 
Although stem cells have been shown to have great medical potential for treating a 
variety of human diseases, this area of research is known to be one of the most controversial 
topics in all of medicine. People often have diverse ethical standpoints because of different  
moral and religious beliefs.  Ethics is a ”branch of philosophy dealing with values relating to 
human conduct, with respect to the rightness and wrongness of certain actions, and to the 
goodness and badness of the motives and ends of such actions” (dictionary.com).   As stem cell 
research developed, many ethical issues arose, including the destruction of early human embryos 
to obtain ES cells for research or therapeutic purposes, the cloning of human embryos to produce 
ES cells specific for one patient, the genetic modification of human stem cells for therapeutic 
purposes, the establishment of stem cell registries with universal access for scientists, the 
establishment of public stem cell banks to ensure universal access for patients, the rights of the 
stem cell and oocyte donors, the rights of the stem cell recipient, the formation of chimeras 
which involve human embryos and/or adults, and the patenting of stem cell lines or associated 
processes or technologies (Stem Cell Primer).  The purpose of this chapter is to discuss some of 
the ethical issues surrounding stem cell research. 
The issue that gets to the heart of most of the above issues is the human embryo and 
when it is considered a living organism. Some may argue a human embryo is alive at the time of 
conception, while others believe it is upon birth. Whichever standpoint one takes changes the 
role the embryo can play in science and medicine, if you adhere to the latter stance the embro is 
not considered living at day-5 when it would be harvested to obtain ES cells to treat a disease or 
to derive a new ES cell line. The two sides which will be presented below offer great arguments, 
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but each individual must decide on their own whether they feel stem cell research is ethically 
right. Although even with this personal conclusion, it does not change the laws that have been 
enacted to govern how far scientists can go with their research. 
It is important to point out from the outset that none of the 5 major world religions are 
against working with adult stem cells (ASCs).  As discussed in chapters 1 and 2, hematopoietic 
stem cells can be isolated from bone marrow or umbilical cord blood, and have been used for 
almost 40 years in bone marrow transplants to save thousands of  human lives.  ACSs can also be 
isolated from a variety of other human tissues, and these cells have been used in animal models 
to treat various diseases.  Because ASCs do not destroy an embryo to obtain them, they have far 
fewer ethical concerns, so the rest of this chapter will focus on embryos for obtaining ES cells. 
 
Stances Against Stem Cell Research 
On one end of the spectrum, many people view the use and research of stem cells as 
unethical.  These individuals view an embryonic stem cell as having the same value as an adult 
human life. Therefore, the deliberate destruction of an embryo is equivalent to the brutal murder 
of an adult human being.  Usually, once ES cells are taken from a 5-6 day old embryo that 
embryo cannot become a whole organism.  They believe that creating a life, to only intentionally 
destroy it for any purpose is wrong.  They believe that scientists are treating a human life as an 
object they can manipulate to benefit the lives of others, without any concern of the potential life 
they are destroying.  In various religious faiths, it is believed that the fetus has a significant 
viability and quickening, with each term relating to the fetus’s personhood. The viability of a 
fetus is considered to be the moment when it is able to independently survive; while quickening 
refers to the time the mother can feel fetal movement.  
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Another pressing issue brings us to the cost of stem cell therapy.  Stem cell treatments are 
very expensive, usually developed by commercial companies and in developed countries.  The 
distribution of these treatments should be set under certain guidelines, although they should be 
accessible by anybody, and they should be made affordable.  In reality there would not be a large 
enough quantity of embryos to provide medical treatment to those who need it even if it was 
made affordable, although new advances in the development of immortal ES cell lines would 
provide a nearly inexhaustible supply if this technnology is perfected.  It would be nearly 
impossible to make the treatment affordable to everyone, and without having a great enough 
supply to treat the needy those who are chosen for treatment are going to be viewed as having a 
superior value on their life.  Ethicists are worried that stem cell therapies and opportunities are 
not going to equally offered to minorities. Stem cell transplantations need to have a close match 
in the cell surface markers and must be conjoined with immunosuppressive therapy. These cell 
surface marker proteins, named HLA types, contain certain haplotypes which appear more 
frequently in certain ethnic populations. In many European countries and in the U.S., the 
majority is of Caucasian decent, meaning the majority of stem cell lines genetically match  
Caucasian patients. This would make the stem cell bank extremely biased, and it would be more 
difficult for one ethnic group to have more opportunities in finding a genetic match. Some people 
believe that a stem cell registry should be created to facilitate locating the most prevailing HLA 
haplotype for each different ethnicity.  
People who are pro-life believe in their faith, that these embryos are a divine creation 
upon conception. Catholicism is considered one of the most precedent opponents of stem cell 
research. Catholics base their lives on the views of the Vatican. The Vatican is extremely 
conservative and pro-life, strongly opposing ES stem cell research under any rationale. The 
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Catholic Church declares that an embryo should be treated equally to that of a person at the time 
of conception, implying that it should be granted the same rights as a person at that time.  
One very important issue in stem cell ethics is the source of the egg that would be used 
for in vitro fertilization (IVF) to provide the embryo. Most embryos are currently provided by 
excess IVF embryos that are normally discarded once a couple has had enough children.  These 
embryos were originally created for reproductive purposes, and their discard when in excess has 
occurred in the U.S. since the early 1970’s.  However, some scientists are currently debating 
using oocytes donated for research purposes.  There are accusations of unethical conduct being 
made stating that the donation centers are not abiding by the Institutional Review Board rules 
and/or gathering the consent of the donors. At Seoul National University, it was found that the 
number of donated oocytes was underreported, and that donors (and even lab workers) were 
pressured into consenting to the donation.  This leads many to question the safety of the donors, 
especially considering their greater risk compared to the donors. 
Ethical concerns also arise when the stem cell recipient is a patient suffereing from a 
disease, and the recipient is a child.  This type of stem cell recipient is under close inspection by 
human rights organizations. Earlier it was explained that donated human stem cells are 
differentiated in culture, then injected into a patient’s bloodstream or tissue.  Many recipients are 
children, but they have not officially been included in clinic trials to date. The reason behind this 
is that a child’s body is still developing, and complications with these changes are unknown.   
Another issue considered unethical is the commercialization of stem cells. Here in the 
United States, there is very limited funding from the federal government for stem cell research, 
as will be discussed in detail in chapter-4.  Because of this, many states and private companies 
are funding the research conducted by scientists. But companies are in it for profit.  Several 
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companies are hurrying to fill patents for stem cell lines, even relocating the companies to other 
countries to ensure their patents are approved. Each country has different views of the ethics of 
patents in relation to stem cell technologies. Various companies are using the access to patented 
stem cell lines in order to later sell and develop stem cell therapies. The commercialization of 
stem cells relates back to treating a human life as an object, for the benefit of others. Here, the 
private companies would benefit from all of the profits made, making it unethical in the eyes of 
opponents of stem cell research.  
 
Ethical Arguments For Stem Cells 
Stem cell research offers unlimited potential in the hope of gaining better knowledge of 
the human body and for treating previously uncurable diseases. Scientists have been discovering 
treatments and drugs for centuries leading to the increased life span of people all over the world. 
If stem cell research continues to grow at a rapid pace, the general health of a great number of 
the population is destined to improve.  Although many of these supporters feel great sorrow of 
the way embryonic stem cells are derived, they also understand the ends of saving thousands of 
lives from one ES cell line justifies the means. Further research could assist in the discovery of 
cures for many life threatening diseases.  
Supporters of stem cell research tend allocate less moral weight to pre-implanted 
embryos, and the destruction of these embryos for research purposes. These people also believe 
it appropriate to use spare embryos from fertility procedures for the sole purpose of medical 
exploration.  Some believe since the embryo has not consented, it is unethical. However, medical 
researchers for some time now have used tissues from murder victims with the consent of their 
relatives, so why not allow embryo donations given the consent of the two parents.  Abortion 
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activists have entered this debate, disclaiming the use of aborted fetuses for research, but IVF 
embryos are not aborted fetuses, and eventually opponents of stem cell research might change 
their viewpoint if the separation of abortion decisions and stem cell research permission is 
separated.  If  lawmakers and ethicists could join together and agree to a specific set of 
guidelines, the use of stem cells for research could potentially be seen as ethical by all.  
The main ethical debate in stem cell research is whether the embryo is a human being, or 
a potential human being.  The argument that made by people who are “pro-life” and opposing 
embryonic stem cell research is they truly believe that embryos destroyed for stem cell research 
are human beings and have to divine right to live.  Those pro stem cell research claim these 
embryos are too young to be considered a full human being with the same rights as a new born 
baby or an adult.  Embryos represent a few hundred cells, about the same size as the period at the 
end of this sentence, less than a grain of sand.  These embryos are not developed, having no body 
or extremities. They lack the ability to hear, see, taste, feel, and think. The only thing these 
embryos have is the possibility of becoming humans, or the potential to cure diseases and save 
the lives of millions.  
Some supporters of stem cell research go beyond supporting the use of embryos to obtain 
ES cell lines, and also support the far more controversial topic of using aborted fetuses to obtain 
embryonic tissues for transplant.  Aborted fetuses are older than the day-5 blastocysts used to 
obtain ES cells.  Supporters of stem cell research believe that it is an individual’s decision on 
whether they chose to terminate a pregnancy. If they chose to do so, why shouldn’t these aborted 
embryos be used to prolong the life of another.  In almost all countries, it is against the law to 
intentionally terminate a pregnancy specifically to obtain ES cells. They do not, however, have 
laws indicating that the naturally aborted embryos cannot be used for research purposes.  
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A rising issue among this heated debate is whether an embryo should be created for the 
sole purpose of research and treatment. Supporters believe that by encouraging donors, this is 
one way to advance the development of cures and treatments.  Some feel this is especially 
appropriate when the ES cells would be used to treat immeidate members of the same family as 
the donor.  Jodi Picoult’s “My Sister’s Keeper” deals with this issue. The couple’s second 
daughter was born genetically matched to her older sister.  Her egg donation prolonged their 
eldest daughter’s life for over 10 years.  In the eyes of a supporter of stem cell research, it would 
be morally wrong to allow the pain and suffering of a living being in order to protect a destroyed 
embryo.  
Some faiths are strong supporters of stem cell research. People of Judaism are among the 
strongest supporters of stem cell research. They believe that it is part of their life and their moral 
duty to save lives. Also, the Torah states that an embryo is considered alive if it has implanted in 
the womb. They believe that early embryos do not reflect a personhood, nor do they have legal 
status. Jews abide to the task of healing, making the use of stem cells in research and therapy 
obligatory. People of Islamic faith are directed under the Shari’ah, where it is believed that a 
person is formed progressively. This progressive formation of life insinuates that life can begin 
at different time periods, ranging from 40 to 120 days.  So with this belief, it makes an early 
embryo available for stem cell research, regardless of whether it was produced for reproduction 
or research.  
Opening the public’s eyes as to the full potential of ES cells might be one way to 
decrease their opposition to stem cell research. If citizens were fully informed of the probable 
cures and how many lives would be saved, perhaps the opposition would diminish. Scientists 
should make their findings and results understandable for the public to assist in their awareness 
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and understanding.  If citizens realized the tangible potential of the various diseases, scientists 
feel they could become supporters. Also, if public citizens were able to conduct meetings and 
discussions with lawmakers and scientists to better understand both sides of the arguments, they 
would see the great potential and become supporters of stem cell research.  Small adjustments to 
stem cell research could swing opponents into finding it ethical. If governments were able to use 
funding to help more people afford the cost of these procedures, fewer would oppose. Millions of 
people lack health insurance, not having access to basic health care, so stem cell procedures for 
them are improbable. In doing this, more people might agree to government funding of stem cell 
research, because if needed, it could be applicable to their personal situation.  
 
Chapter-3 Conclusion 
The authors of this IQP report are pro stem cell research. We strongly support the use of 
federal and state funding to further explore stem cells, and believe this will benefit society as a 
whole. With the information we have accumulated preparing this report, we believe that the ends 
do justify the means in this case. Although many see the use of excess IVF embryos as unethical, 
we believe it to be perfectly humane. The decision should belong solely to the family involved in 
the original creation of the embryos for reproductive purposes, and we strongly support their 
decision to allow the embryo to be used in the medical research for stem cells. Although we are 
part of the Catholic Church, we feel that there is now a need to look past our religious faiths to 
see the good that will come from stem cells. In all that we believe, it is unethical for us to push of 
own religious beliefs on another or hold their decisions against them. In the use of donated 
excess IVF embryos to obtain ES cells, or even the more controversial use of aborted embryos to 
botain embryonic tissues, we point out that the potential life created has already been lost, either 
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by the parents not wishing to implant any more IVF embryos, or the involutary natural abortion 
of a fetus.  It would only be proper to use these embryos to help prolong the lives of others from 
the treatments offered through stem cell research.  
One step I have taken to show my support for stem cells is by becoming a bone marrow 
donor.  In doing this, I hope to one day be able to lengthen the life of another human being who 
could use my hematopoietic stem cells to save himself from some types of blood cancers. Later 
in life, I plan to donate any umbilical cords I obtain through the births of my children. I believe 
that scientists have come so far in their research to show excellent life saving potentials, that the 
opposition is now harmful to society.  I think that federal, state, and local governments should 
fund this research in order to decrease the time it takes to find these potential cures and 
treatments. I also feel that if governments could come to an agreement with citizens in regards to 
funding and distribution of treatments, stem cell research would be able to flourish.  
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Chapter-4:  Stem Cell Legalities 
 
 In recent years, the progressions scientists have been making concerning stem cell 
research are astounding, and the developments surrounding stem cells bring hope for cures to 
diseases once deemed impossible to alleviate. These breakthroughs have gained scientists respect 
and recognition, but have also gained attention from many people including everyday citizens to 
lawmakers across the nation. In fact, the stem cell topic has a large outreach around the entire 
world.  As is the case for any controversial technology, laws have been enacted to control it.  The 
purpose of this chapter is to discuss some U.S. federal, U.S. state, and international laws 
regulating stem cells. 
 
U.S. Federal Stem Cell Policies 
 In order to understand the hype around stem cells, it is necessary to first look at the 
policies concerning stem cell usage that have been enacted during the last twenty years. Recently 
it seems that each incoming President has different opinions on the subject of stem cell research. 
The first President to actively involve himself in stem cell research was President Clinton.  Prior 
to his election, the issue was always overlooked and frowned upon.  Almost immediately after 
Clinton’s election, the NIH Revitalization Act of 1993 was passed. The substantiality of this 
single passing was enormous because a 20-year freeze on fetal transplant research was ended.  
The main outcome of this law was congressionally sanctioning in vitro fertilization (IVF) 
without the need for approval from the Ethics Advisory Board. Although researchers were able 
to pass over the advisory board, President Clinton formed a research panel to oversee the ethical 
aspects of the research being done. This panel consisted of various types of scientists, lawyers, 
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and ethicists. President Clinton allowed this research but only supported funding for research on 
non-human embryos, and also banned federal funding for research of embryos created by IVF, 
parthenogenesis, and cloning solely for the purpose of research. Congress sided with the 
President and continued to enforce this order through his presidency. Extra embryos frozen in 
IVF clinics originally created for reproductive purposes didn’t fall under the ban, so for this 
reason research was conducted on these embryos.   
President Clinton had one more major order in the funding of stem cells before the end of 
his presidency. In 2000, federal funds were allocated for research on stem cell lines that had been 
developed from extra embryos using private funds.   This allowance of federal funds came in 
large part due to the head lawyer from the Department of Health and Human Services, Harriet 
Rabb.  First of all it is necessary to understand exactly what was standing in the way of federal 
funds.  The Dickey-Wicker Amendment is the ban that prevents federal funds from aiding 
research on embryos. However, Harriet Rabb argued that embryonic stem (ES) cells were not in 
fact “embryos” by way of definition. Due to this argument the NIH was allowed to give federal 
funding to experiments involving only stem cells themselves. 
 The NIH Human Embryo Research Panel came out with a number of proposals during 
the presidency of Bill Clinton. Even though President Clinton put the panel into place he didn’t 
back all the recommendations they made. This panel stated that human embryos could be created 
and worked on as long research on each embryo didn’t surpass 14 days.  Prior to 14 days the 
brain and nervous system isn’t developed in an embryo and in the opinion of the panel without 
these systems it was humane to research these embryos. But this topic was never looked into, 
along with many other proposals, because President Bush had very different stem cell research 
guidelines. 
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 As soon as he was elected to office, President Bush firmly stood up for his beliefs 
concerning stem cells and made major changes. President Bush is firmly against the idea of using 
human embryos for anything, and for human cloning, which is a main factor driving many of the 
acts passed during his presidency.  In his opinion “no human life should be started or ended as 
the object of an experiment.” President Bush also went on to say that life begins as soon as an 
embryo is formed.  This makes human embryos people, meaning terminating them for research 
would be the same crime as using a death row inmate for research. President Bush wants to limit 
the power of scientists due to the fact that in essence they can easily create and destroy human 
life. 
During his first year as president, the research panel put in place by Clinton was replaced 
with the President’s Council on Bioethics.  In 2001, President Bush declared that scientists 
receiving federal research funds could only work with ES cell lines that had been in existence 
prior to August 9, 2001. The White House claimed that there were seventy-eight usable lines at 
that time; however scientists now state that after testing the cell lines only about a third of these 
lines are viable.  
With this 2001 act clearly in place, the boundaries that revolve around it have become 
slightly blurred. Questions arise concerning exactly what defines cloning and creating/destroying 
life, and many scientists feel the answer is neither black nor white. The actual definition of 
cloning differs greatly depending on who is asked the definition. In society the word “clone” has 
been given a meaning that in some cases makes people frightened. They feel a clone is an exact 
replica of another person, when in reality scientists give the word clone a much different 
meaning. To them cloning is simply making a copy of something else. It doesn’t have to 
necessarily be an entire human body; it could be something as small as a cell. Since no federal 
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funding can be used for research, absolutely nothing using ES cell lines derived after 2001 or in 
human cloning can be federally funded, not the equipment, not the facilities, nothing. Many 
scientists have had to move to new labs in order to ensure that none of their work occurs in a 
place federal funds have gone into. This action has, in some peoples’ opinion; singlehandedly 
halted the vast progress researchers were making. Many feel that because of this ban research is 
actually going backwards, and in some respects stem cell research is returning to where it was 
prior to President Clinton’s time in office. 
Although no more stem cell lines have been created using federal funds, privately funded 
projects are still legal. Some scientists feel that federally funded ES cell lines should not be used 
in human clinical trials because they are maintained on mouse feeder cells, and so may contain 
mouse proteins.  However, privately funded lines have been produced with no animal influences, 
and continue to be studied throughout the United States. These lines are easier to access and 
easier to maintain than previously created ES lines. 
At this time, privately funded stem cell lines are one of the key tools in advancing stem 
cell research. The debate revolving around this fact has sparked many people to push for 
President Bush to loosen his stance. Some who oppose Bush’s principles feel it is risky to leave 
all the stem cell progress to private sectors. Lead arguments for this statement center around the 
fact that privately funded facilities don’t need to follow ethical guidelines of the American 
government and its citizens, thus by being so restrictive federally, stem cell research would 
increase in the private sector but with less oversight. Also some fear that the strict restrictions on 
scientists could cause the researchers to move to private labs or to countries with more lenient 
policies, instead of remaining in government supported ones. This shift could leave the nation 
behind in many areas, which could potentially harm the country over time. 
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With the enactment of this law in August of 2001, $250 million was promised for the 
research of adult stem cells from other sources in the body.  This restriction also went hand in 
hand with the Human Cloning Prohibition Act passed by the House in July of 2001, stating that 
no human embryo can be cloned for any reason. As a law the punishment for cloning would be 
an imprisonment of up to ten years and a one million dollar fine. Despite the fact that President 
Bush hasn’t backed down from his stance on embryonic stem cell research, he has acted in order 
to avoid legal battles involving this research. Bush appointed Elias Zerhouni to work as a 
mediator between the government, companies, and universities studying stem cells. He worked 
to reduce conflict, while at the same time allowing some research to continue. 
As time went on the debate concerning stem cells became so heated that it was actually a 
campaign issue during the 2004 Presidential Election. The support of research was split with 
President Bush remaining steadfast with his strict stance, while his opposing candidate, John 
Kerry, vowed to expand funds.  Although it isn’t a clear cut division, in general the Democratic 
Party is more supportive of stem cell research. Many democrats feel very passionate about the 
significance of stem cell research and the advancements in science that could come as a result of 
research. With the second term re-election of President Bush he continued to support adult stem 
cell research without backing embryonic stem cells.  
However President Bush’s support was starting to falter from some people who originally 
backed his stance. In 2004, 58 United States Senators sent a letter to Bush trying to push him to 
expand the eligibility of federally funded lines. The House of Representatives also sent a letter to 
the President with 206 signees. The supportive members of the house wanted to include extra 
embryos produced through IVF fertilization to the list of those acts acceptable to federally 
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research.  But in 2006 Bush vetoed a bill from Congress to lift these restrictions, and when 
subsequently voting to try to overrule the President’s veto, the supporters were 4 votes short. 
 
U.S. State Stem Cell Laws 
Despite federal laws, stem cell laws have been passed in many states that provide bond 
funding for stem cell research or which allow private institutes to study stem cells. Some states 
have taken the forefront of stem cell research by developing some of the best research facilities 
in the country, especially California, New Jersey, Massachusetts, and Wisconsin. The facilities in 
these states use private funds and state funds to perform stem cell research, and are making a 
huge impact on the scientific community.  
The first state to outwardly support stem cell research in the United States was California. 
In 2002 a bill was proposed, and later in 2004 it actually passed. Proposition 71 was passed and 
provided $3 million dollars over a span of 10 years to fund stem cell research (Chamany, 2004). 
This research includes experiments with embryos produced through cloning, but this bill did not 
support creating a cloned human being. This proposition 71 had the backing of many businesses, 
including Microsoft, because industries usually indirectly benefit from successes in research. 
Initially, California citizens were slightly less supportive of the bill, but after a state wide 
campaign the bill passed.  
Even though California’s proposition 71 was approved, lawsuits have been filed against 
the state with claims that have both been dismissed in lower courts, but are now on the way to 
the Supreme Court.  These cases deal with protests that the overseeing council has no right to use 
state funds because it isn’t under the state’s control.  The biggest fear of protestors is that stem 
cell research has the potential to become unethical, if research goes in a direction different from 
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what the public wants, there is virtually no way to stop it. An amendment was eventually placed 
on the bill which further protected egg donors to prevent them from being taken advantage of. 
One giant advance in stem cell research is occurring due to a company based in California, the 
first adult stem cell bank has been opened.  Donors are able to give their stem cells, via donations 
of bone marrow, umbilical cord blood, or autopsy tissues, to research which is a huge step in the 
right direction according to supporters of stem cell research. 
The next state to follow California’s lead was New Jersey.  In fact New Jersey was the 
first state to establish a state supported stem cell research facility. This state also allows research 
on any embryos, which is a big step considering the limited federal rulings on such issues. Two 
successive governors of New Jersey had large roles in allowing this research, and many of their 
plans pushed for support of these studies. They have also pushed unspent bond money to support 
this research.  
Massachusetts under former Governor Mitt Romney was initially against ES cell 
research, but under current Governor Patrick in 2008 funded a state bond to supply one billion 
dollars for its Bioinitiatives Proposal (Estes, 2007) to help fund stem cell research, and to 
establish a very large stem cell bank at the University of Massachusetts, Worcester.  Initially, 
many of the state’s strong universities pushed hard to allow stem cell research, but then 
Governor Mitt Romney stood in their way.  Eventually in 2006 the state senate passed a law 
allowing stem cell research (Klein, 2006), but Governor Mitt Romney vetoed it.  Only when 
Gov. Patrick was elected did the state bond pass (Estes, 2007). 
Other states have been restrictive in their stem cell policies.  States including Arkansas, 
Indiana, Michigan and especially South Dakota, have made strict stem cell laws.  In South 
Dakota, its laws may be the most restrictive in the nation, since they have a zero tolerance policy 
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for ES cell research, there it is against the law to study anything from embryos. In the other listed 
states, research on cloned embryos is forbidden.  
With all the differing opinions from state to state, it brings up the question of what the 
United States citizens feel in regards to stem research.  Poll results show that a large portion of 
people feel President Bush should become a little more lenient in his position, 70% of Americans 
want some restrictions lifted.  Of these supporters, more than half are conservatives, which show 
the path the U.S. may be taking in years to come. 
 
International Laws on Stem Cells 
Around the world, stem cells are a common research topic with many nations taking 
interest in this area of science.  Some countries in particular stand out among others to lead the 
forefront of this revolutionary subject, while others have completely banned ES cell research.  
In 2001, France and Germany lead the way with a unified push to establish an 
international agreement to the United Nations to ensure that cloning did not occur in countries 
that didn’t enact their own laws concerning this topic (Chamany, 2004).  A draft was 
constructed; however the vote for it was postponed until 2005. Many different countries have 
displayed interest in stem cell research, and each has contributed differently to the general 
advancement of this research. After many years of debate, a general consensus was achieved in 
the United Nations to ban all forms of human cloning that do not protect human life. In the ban 
the term “human life” was used which brings up questions about whether an embryo is 
considered to be a living human. This ban is not as strict as some countries would like and is too 
restrictive for others; so many nations have been creating laws of their own pertaining to stem 
cells. 
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In the United Kingdom, laws stated that embryos used for therapy is legal, but only 
embryos created in vitro are eligible (Chamany, 2004). This law was eventually extended to 
create embryos created through SCNT.  In order to keep ethics in check, the United Kingdom has 
a central stem cell registry and boards in place to regulate research and cell lines. The United 
Kingdom is actually one of the first nations to outwardly support SCNT.  In comparison to other 
nations England is one of the most lenient in its stem cell laws. 
On the other end of the spectrum, Germany and Italy have some of the strictest stem cell 
laws internationally. In Germany, the only ES cell lines allowed to be researched had to be in 
existence before 2002, or lines that were imported. Also it is a criminal act for researchers to 
give any information to researchers from other countries. Italy has even stricter laws which ban 
all embryo research. Government officials have even gone as far as to ban sperm and egg 
donations.  A major concern of these conservative countries seems to enforce a no tolerance 
policy of cloning, however some feel the harsh actions are hindering stem cell research. 
Most countries find themselves is in the middle of the spectrum, in terms of leniency of 
stem cell research. Examples include Australia, China, and Canada.  In China, cloning is allowed 
as long as it is for therapy. Also Chinese scientists have access to embryos and fetal tissues, and 
SCNT is legal. Canadian scientists have full access to ES cell lines and excess in vitro embryos, 
but SCNT is not allowed, and embryos from IVF must younger than 14 days and aren’t allowed 
to be created in Canada.  Bills passed in Australia have banned reproductive cloning, but do 
allow embryo research.  Australia has a government which is severely split concerning the 
allowance of stem cell research, so laws are still being worked out to determine exactly what 
should be legal within this country. 
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Other countries have found it hard to enact any stem cell policies, which show why it has 
been so hard for the United Nations to develop any unified policy that works for all these 
nations. It is promising that with more advancement in research the United Nations will be able 
to develop a complete set of guidelines for researchers around the world to bring stem cell 
research to a whole new level. 
 
Chapter-4 Conclusions 
Whether it is on a state, national, or world level, stem cell research is highly debated and 
is a very heated topic. Although progress has been made in many areas to reduce conflict, it will 
take some time until all the problems surrounding stem cells work themselves out. However the 
hope that stem cell research brings to the science and medical worlds keeps many people 
optimistic about the advances that will come from stem cell research. 
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CONCLUSIONS 
 
 At this time, stem cell research is one of the most controversial topics facing the scientific 
community.  The immense information that has recently become available on this technology for 
view by the general public has allowed many to develop their opinions based on misinformation, 
thus this project aims to help clarify key debate points in this exciting new field.  Based on the 
information discussed in this IQP, the authors also provide their own conclusions and 
recommendations. 
In terms of the types of stem cells used for research, the authors of this IQP agree that 
both embryonic stem (ES) cells and adult stem cells (ASCs) should be supported by federal 
dollars, and made readily available for research.  As to the source of the embyos used to derive 
the ES cells, neither author has a problem using excess in vitro fertilization (IVF) embryos 
provided with donor consent.  The embryos should not be produced solely for the purpose of 
research, however IVF embryos developed for reproductive purposes are acceptable. ES cells 
have the potential to be one of the most beneficial tools in the treatment of many diseases once 
thought to be incurable, and the authors strongly support research on these cells.  
In terms of ethics, both authors agree that because stem cells offer hope in prolonging and 
bettering human life this far outweighs the risks some associate with these studies, including the 
destruction of a 5 day old blastocyst to derive ES cell lines.  The donation of umbilical cords, 
bone marrow, and other sources of stem cells are also completely ethical and should be 
encouraged, funded, and used to fight diseases whenever possible.  
In terms of laws governing stem cell use, we support laws allowing the federal funding of 
both ES cell and ASC research.  Countries like England, Sweden, and China have lenient stem 
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cell laws, and both authors feel the United States should follow their lead.  In addition, more 
states need to enact laws like those passed in California, New Jersey, and Massachusetts, to help 
fund stem cell research. 
 
